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Invasive rhino-orbito-cerebral mucormycosis, a
rare opportunistic fungal infection which can
rapidly lead to death is strongly associated with
diabetic ketoacidosis.
Case report
A 52-year-old Indian woman presented to hospital
with a one-week history of right-sided retro-
orbital pain and facial swelling. She had no other
signiﬁcant past medical history.
On examination, she was found to be apyrexial
with a pulse rate of 100 min
–1 and confused.
She also had evidence of right-sided periorbital
cellulitis. Cranial nerve examination conﬁrmed
decreased visual acuity in the right eye (6/9) but
with a full range of extraocular muscle move-
ments. She was also noted to have an ipsilateral
mild facial nerve weakness (House-Brackmann
classiﬁcation grade II).
Blood tests revealed a neutrophilic leukocytosis
(31.6 x 10
9/L) with a C-reactive protein of 456 mg/
L and random blood glucose of 56.1 mmol/L.
Urine dipstick analysis identiﬁed the presence of
ketones and blood gas analysis conﬁrmed a meta-
bolic acidosis. A clinical diagnosis of diabetic
ketoacidosis was made and the patient was
treated aggressively with intravenous ﬂuid repla-
cement, intravenous antibiotics (co-amoxiclav
and metronidazole) and commenced on an
insulin sliding scale.
An extended CT of the head including both
orbits conﬁrmed right periorbital cellulitis, with
a degree of stranding of the extraconal adipose
tissue consistent with Chandler classiﬁcation
grade II (Figure 1). There was no evidence of any
intra-orbital collection or intracranial extension.
However, imaging of the paranasal sinuses con-
ﬁrmed complete opaciﬁcation of the right nasal
cavity, maxillary and frontal sinuses, which were,
therefore, presumed the source of sepsis.
The patient underwent an urgent endoscopic
exploration under general anaesthesia. This
revealed a large necrotic mass in the right nasal
cavity which was excised and biopsies sent for
histopathology, microscopy and sensitivity. Histo-
pathological assessment revealed fungal invasion.
The fungal hyphae were seen to be broad and dis-
torted, branching at right angles and surrounded
by extensive necrotic debris. No septae were
present. The right nasal cavity and the involved
paranasal sinuses were exenterated and irrigated.
In view of the intraoperative ﬁndings and the his-
topathology report, parenteral amphotericin B
was also added to the treatment regime. Despite
an initial transient improvement in terms of her
temperature and conscious level, the cranial neu-
ropathies persisted and she subsequently deterio-
rated becoming more confused and losing vision
completely from the right eye. An MRI scan of
the head revealed evidence of predominantly
right frontal cerebritis with early abscess for-
mation (Figure 2). This was arising through
direct extension from the nasal cavity into the
frontal lobes, through the cribiform plate.
Re-accumulation of ﬂuid and thickening of the
mucosa in the paranasal sinuses was evident radi-
ologically but now with disease also affecting the
sphenoid and ethmoid sinuses.
Further surgery including a right maxillectomy
was performed, via a lateral rhinotomy approach.
An orbital exenteration was also done as the right
eyewas found to be necrotic. The frontal sinus was
opened and the mass seen to be extending into the
dura. The dura was, therefore, also opened and
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1necrotic cerebral parenchyma removed followed
by repeated irrigation.
Postoperatively, the patient was transferred to
the Intensive Care Unit (ICU) but failed to
recover. She died 6 days later following a general-
ized seizure.
Discussion
Mucormycosis is a rare opportunistic infection
caused by fungi of the class Zygomycetes com-
monly found in soil and decomposing plant
materials including fruits.
1,2 Infection can be
acquired via inhalation, ingestion or direct inocu-
lation of wounds with the fungal spores.
3 Mucor-
mycosis is a very aggressive, often fatal, disease
almost exclusively affecting patients with an
underlying immunosuppressive disorder, most
commonly diabetes mellitus and haematological
disorders.
1,4 Iron overload is also an important
predisposing factor.
2 It equally affects both sexes
and can present at any age. It can involve
any body system.
1,3 Rhino-orbito-cerebral
mucormycosis (ROCM) is the commonest form
accounting for almost half of all cases.
2,3
ROCM isthought to arise most commonly from
inhalation of the fungus into the paranasal
sinuses. Subsequently, upon germination, it can
rapidly spread to involve neighbouring structures
including the cavernous sinus, orbits and brain. In
particular, the fungus has an afﬁnity for the
internal elastic lamina of arteries through which
it can haematogenously disseminate to distant
sites.
2 This process of cerebral angioinvasion pro-
duces extensive endothelial damage that can
lead to mycotic aneurysms, dissection and/or
thrombosis of the internal carotid artery with sub-
sequent cerebral infarction.
3 It can occur
rapidly accounting for the very high mortality
associated with ROCM, even with aggressive
treatment.
4
As patients with ROCM may initially present
with signs and symptoms mimicking bacterial rhi-
nosinusitis and/or periorbital cellulitis and
appear clinically stable (apyrexial in 50% of cases
although leukocytosis is typically present – pro-
vided the bone marrow is functional - as in our
case), the diagnosis is often missed until the
Figure 1
CT head including both orbits illustrating right
periorbital cellulitis, with a degree of stranding of
the extraconal adipose tissue (but no evidence of
intra-orbital collection) consistent with Chandler
classiﬁcation grade II. Associated complete opa-
ciﬁcation of the right nasal cavity is evident
Figure 2
MRI brain revealing evidence of predominantly
right frontal cerebritis with early abscess
formation
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2disease has signiﬁcantly progressed, dramatically
worsening the prognosis.
2,3 The additional
presence of a headache, orbital inﬂammation,
visual changes or multiple cranial nerve palsies
should raise the suspicion of ROCM.
3 This is par-
ticularly true if the patient is diabetic, as 70% of
ROCM cases occur in patients in diabetic
ketoacidosis.
2,5
If ROCM is suspected, prompt evaluation with
radiological imaging and nasal endoscopy with
biopsy of abnormal-looking tissue is mandatory
to exclude the diagnosis.
2 Imaging modalities
include CT and MRI. CT is useful in assessing
the disease extent and typically shows mucosal
thickening, opaciﬁcation of the affected paranasal
sinuses and periorbital tissue destruction. More-
over, it can display intracranial complications
such as the presence of a cerebral abscess. CT is
the optimal imaging modality to assess for bony
destruction although this is often seen only late
in the course of the disease.
6
Alternatively, MRI (including MRA and MRV)
is superior in visualizing and evaluating intracra-
nial and intradural extent of the disease including
thrombosis of the cavernous sinus and cavernous
portion of internal carotid artery as well as soft
tissue inﬂammation (e.g. in the orbit). The use of
contrast enhancement aids the visualization of
perineural spread of the disease.
3
However, it is very important to appreciate that
in early ROCM both CTand MRI may be normal as
radiological ﬁndings lag behind clinical pro-
gression.
2,3 Hence, in high-risk patients, it is man-
datory to progress to urgent endoscopic
evaluation of the nasal cavity with biopsy of any
suspicious areas.
3 Although frozen section has a
role in expediting diagnosis and guiding the
extent of surgical debridement,
7 the gold standard
for diagnosing ROCM is histopathological examin-
ation of biopsy specimens. This typically demon-
strates fungal invasion as evident by the presence
of fungal hyphae branching at right angles and
extensive necrotic debris surrounding the fungi,
as in our case.
3,8 Fungal culture has a poor speci-
ﬁcity and sensitivity as the organism is found in
normalsubjectsandmaybekilledduringspecimen
preparation. Serological, PCR-based and skin tests
are all unreliable for ROCM.
2
The differential diagnosis of ROCM includes
sinusitis due to other opportunistic pathogens
such as Aspergillus, as well as neoplastic disease,
in particular lymphomas of the paranasal
sinuses associated with HIVand AIDS.
8
As ‘time is of the essence in the management of
mucormycosis’,
2 treatment needs to be started as
soon as clinical suspicion is present in a high-risk
patient. This is to enhance survival and minimize
the signiﬁcant morbidity associated not only with
the disease itself but also with the aggressive
surgical debridement needed in the majority of
cases. Treatment is multi-disciplinary and com-
prises of reversal of the underlying immuno-
suppresion (where possible), high-dose systemic
anti-fungal therapy and radical surgical debride-
ment.
1,7 Anti-fungal medications administered
systemically in ROCM include intravenous liposo-
mal amphotericin B in combination with parent-
eral posaconazole, a newer broad spectrum
anti-fungal.
3 However, not all fungal strains are
susceptible to these medications.
2 In addition,
because of the angioinvasion caused by the
fungi, vascular supply to affected body parts is
poor, often preventing systemic medication from
reaching the fungus to eradicate it.
2,3 Thus, early
aggressive surgical debridement is the key to suc-
cessful treatment of ROCM.
3 Indeed, in a case
series of 49 patients with ROCM, the survival
rate was 30% in patients treated with anti-fungal
medication only while in those patients that
received a combination of anti-fungal medication
plus surgery survival was 86%.
9,10 Surgical treat-
ment for ROCM often includes multiple repeat
operations and may involve orbital exenteration
and even removal of necrotic brain tissue, as in
our case.
3
Despite, this radical approach to treatment, the
mortality associated with ROCM ranges from 50–
80%, rising to >90% when disease is disseminated
even without involvement of the central nervous
system.
2,7
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